Hotline:400-8201-126 中文 | English

Aims to become a giant in the global blood products industry

Research areas of RAAS mainly focus on the plasma-derived products and recombinant protein such as coagulation factors.

• Research and development of plasma-derived products

By using advanced state-of-art biological engineering technology, it is focused to improve the traditional processing technology and increase the yield and quality of blood products, including the current several kinds of products, like human albumin, immunoglobulin, prothrombin complex (PCC), coagulation factors, fibrinogen products. On the other hand, we are actively seeking and developing other new and valuable plasma-derived products.


• Research and development of genetically engineered recombinant products

Using modern genetic engineering technology to develop recombinant protein products and explore new pipeline, mainly focusing on coagulation factors.

Links:Tonrol Bio-Pharmaceutical Co., Ltd.,

Internet drug information service certificate :( Shanghai) Non-operating 2011-0201  Copyright © 2013-2014 Shanghai RAAS   All rights reserved  Powered by Yongsy